These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24184271)

  • 1. Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter.
    Pelham C; Jimenez T; Rodova M; Rudolph A; Chipps E; Islam MR
    Biochim Biophys Acta; 2013 Dec; 1829(12):1257-1265. PubMed ID: 24184271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mRNA expression is responsive to intracellular and extracellular iron loading: short communication.
    Mehta KJ; Farnaud S; Patel VB
    Mol Biol Rep; 2017 Oct; 44(5):399-403. PubMed ID: 28840425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.
    Ryan JD; Ryan E; Fabre A; Lawless MW; Crowe J
    Hepatology; 2010 Oct; 52(4):1266-73. PubMed ID: 20658468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells.
    Riedel HD; Muckenthaler MU; Gehrke SG; Mohr I; Brennan K; Herrmann T; Fitscher BA; Hentze MW; Stremmel W
    Blood; 1999 Dec; 94(11):3915-21. PubMed ID: 10572108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the hemochromatosis protein HFE: Lessons from animal models.
    Pantopoulos K
    World J Gastroenterol; 2008 Dec; 14(45):6893-901. PubMed ID: 19058322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
    Wu Q; Wang H; An P; Tao Y; Deng J; Zhang Z; Shen Y; Chen C; Min J; Wang F
    Antioxid Redox Signal; 2015 May; 22(15):1325-36. PubMed ID: 25608116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible roles of the hereditary hemochromatosis protein, HFE, in regulating cellular iron homeostasis.
    Enns CA
    Biol Res; 2006; 39(1):105-11. PubMed ID: 16629171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell.
    Huang D; Wang Y; Wang L; Zhang F; Deng S; Wang R; Zhang Y; Huang K
    PLoS One; 2011; 6(10):e27123. PubMed ID: 22073128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased duodenal DMT-1 expression and unchanged HFE mRNA levels in HFE-associated hereditary hemochromatosis and iron deficiency.
    Byrnes V; Barrett S; Ryan E; Kelleher T; O'Keane C; Coughlan B; Crowe J
    Blood Cells Mol Dis; 2002; 29(3):251-60. PubMed ID: 12547214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.
    Gao J; Chen J; De Domenico I; Koeller DM; Harding CO; Fleming RE; Koeberl DD; Enns CA
    Blood; 2010 Apr; 115(16):3374-81. PubMed ID: 20177050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.
    Kelleher T; Ryan E; Barrett S; Sweeney M; Byrnes V; O'Keane C; Crowe J
    Gut; 2004 Aug; 53(8):1174-9. PubMed ID: 15247188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.
    Schmidt PJ; Andrews NC; Fleming MD
    Blood; 2010 Dec; 116(25):5679-87. PubMed ID: 20837779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.
    Nicolas G; Andrews NC; Kahn A; Vaulont S
    Blood; 2004 Apr; 103(7):2841-3. PubMed ID: 14656876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
    Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
    Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo.
    Costa M; Cruz E; Oliveira S; Benes V; Ivacevic T; Silva MJ; Vieira I; Dias F; Fonseca S; Gonçalves M; Lima M; Leitão C; Muckenthaler MU; Pinto J; Porto G
    PLoS One; 2015; 10(4):e0124246. PubMed ID: 25880808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.
    Gao J; Chen J; Kramer M; Tsukamoto H; Zhang AS; Enns CA
    Cell Metab; 2009 Mar; 9(3):217-27. PubMed ID: 19254567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
    Herrmann T; Muckenthaler M; van der Hoeven F; Brennan K; Gehrke SG; Hubert N; Sergi C; Gröne HJ; Kaiser I; Gosch I; Volkmann M; Riedel HD; Hentze MW; Stewart AF; Stremmel W
    J Mol Med (Berl); 2004 Jan; 82(1):39-48. PubMed ID: 14618243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.